To assess the influence of miR155 on the anti-tumor efficacy of anti-CD19 CAR-T cells, we co-cultured miR155 over-expressing anti-CD19 CAR-T cells with CD19-positive target cells. This evidence concerns the gene CD19 and neoplasm.